Fintel reports that on March 17, 2025, Lake Street initiated coverage of Axogen (NasdaqCM:AXGN) with a Buy recommendation.

Radiation-resistant nanomaterials enhance durability in nuclear systems by mitigating damage, improving structural integrity, ...

RNV secures Thailand marketing approval for its NervAlign repair product Product suited to country’s booming plastic ...

As global populations age, neurological disorders such as Alzheimer's, Parkinson's, and epilepsy become more prevalent.

given their strong local positioning and in-depth understanding of the biomaterials and surgical markets, including the peripheral nerve repair market,” he said.

Thank you, Mike. To start we believe Axogen's planned peripheral nerve repair market development priorities represents a $5 billion TAM opportunity with significant potential to improve patients ...

Thomas Chabanis as General Counsel. These appointments reinforce TISSIUM’s executive team as the company advances toward key milestones, notably the launch of its first commercial product, COAPTIUM ...

Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are ...

Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are ...

Following an injury, such as a traumatic crush injury, the peripheral nervous ... themselves into repair cells when needed. Unfortunately, the regeneration of nerve cells can be inefficient ...